P2‐029: rationale and design of a prospective, randomized, double‐blind, dose‐comparison safety and tolerability study of grf6019 in mild‐to‐moderate alzheimer's disease
Alzheimer's & Dementia（2006）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要